4.5459
Bio Key International Inc stock is traded at $4.5459, with a volume of 3,231.
It is down -2.03% in the last 24 hours and up +16.56% over the past month.
BIO-key International Inc is a identity and access management (IAM) platform provider enabling secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and high-quality, low-cost accessory fingerprint scanner and FIDO-compliant hardware to provide a full and complete solution for identity-innovating customers. The company operates as one operating segment. Its solutions are Passwordless Authentication, Secure Roving Employees, Education, Financial Services, Government, Healthcare, Manufacturing, etc.
See More
Previous Close:
$4.64
Open:
$4.51
24h Volume:
3,231
Relative Volume:
1.31
Market Cap:
$4.93M
Revenue:
$6.63M
Net Income/Loss:
$-4.06M
P/E Ratio:
-0.8234
EPS:
-5.5206
Net Cash Flow:
$-4.20M
1W Performance:
-1.18%
1M Performance:
+16.56%
6M Performance:
-39.24%
1Y Performance:
-45.98%
Bio Key International Inc Stock (BKYI) Company Profile
Name
Bio Key International Inc
Sector
Industry
Phone
(732) 359-1100
Address
101 CRAWFORDS CORNER RD, HOLMDEL
Compare BKYI vs MSFT, ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BKYI
Bio Key International Inc
|
4.5459 | 4.93M | 6.63M | -4.06M | -4.20M | -5.5206 |
|
MSFT
Microsoft Corp
|
381.70 | 2.84T | 318.27B | 125.22B | 72.92B | 16.79 |
|
ORCL
Oracle Corp
|
114.99 | 331.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
|
PLTR
Palantir Technologies Inc
|
122.92 | 294.68B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
CRWD
Crowdstrike Holdings Inc
|
183.28 | 186.63B | 5.09B | -24.89M | 1.43B | -0.0471 |
|
FTNT
Fortinet Inc
|
152.37 | 111.63B | 7.11B | 1.95B | 2.44B | 2.5883 |
Bio Key International Inc Stock (BKYI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-21 | Upgrade | Maxim Group | Hold → Buy |
Bio Key International Inc Stock (BKYI) Latest News
BIO KEY INTERNATIONAL INC SEC Filing (Jul 24, 2026) - Stock Titan
BIO-key International (NASDAQ: BKYI) sets 2026 director votes, pay ballot and new auditor - Stock Titan
BIO-key International Inc. (BKYI) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
BIO-key Discloses Orders From A ‘Foreign Defense Ministry’ – BKYI Stock Gains - Stocktwits
BIO-key International, Inc. Actuals & Estimates (NASDAQ:BKYI) - TradingView
12 Information Technology Stocks Moving In Friday's Pre-Market Session - Sahm
BIO-key International (BKYI) Changes Independent Auditor to M&K CPAS, PLLC in July 2026 - Minichart
BIO-key (NASDAQ: BKYI) appoints M&K CPAS as new independent auditor - Stock Titan
BIO-key regains Nasdaq compliance - MSN
Price to book forward of BIO-key International, Inc. – NASDAQ:BKYI - TradingView
Enterprise value to revenue forward of BIO-key International, Inc. – NASDAQ:BKYI - TradingView
Price to earnings forward of BIO-key International, Inc. – NASDAQ:BKYI - TradingView
Price to sales forward of BIO-key International, Inc. – NASDAQ:BKYI - TradingView
BIO-key International, Inc.(NasdaqCM: BKYI) added to NASDAQ Composite Index - marketscreener.com
BKYI Forecast — Price Target — Prediction for 2027 - TradingView
BIO-key shares to resume trading on Nasdaq Wednesday By Investing.com - Investing.com South Africa
BIO-key International Trading Reinstated on Nasdaq Capital Market - TipRanks
BIO-key shares to resume trading on Nasdaq Wednesday - Investing.com
BIO-key Regains Nasdaq Compliance; Trading to Resume July 8 - TradingView
Nasdaq restores BIO-key (NASDAQ: BKYI) trading after listing compliance - Stock Titan
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th - The Manila Times
BIO-key International Regains Nasdaq Capital Market Listing Following Compliance Review - Quiver Quantitative
BIO-key regains Nasdaq compliance; trading resu... - Pluang
Lotte Chairman Shin Calls Bio "Key Industry" in Songdo Plant Visit - Seoul Economic Daily
BKYI Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Surprise Amid Revenue Uncertainty - dars.gov.et
Enterprise value to EBIT forward of BIO-key International, Inc. – OTC:BKYI - TradingView
Price to book forward of BIO-key International, Inc. – OTC:BKYI - TradingView
Price to sales forward of BIO-key International, Inc. – OTC:BKYI - TradingView
Enterprise value to EBITDA forward of BIO-key International, Inc. – OTC:BKYI - TradingView
BIO-key International | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan James David - Moomoo
BIO-key (NASDAQ: BKYI) CLO granted 250 shares via ESPP - Stock Titan
BIO-key International | 4: Statement of changes in beneficial ownership of securities-Officer DEPASQUALE MICHAEL W - Moomoo
BIO-key (BKYI) CEO adds 250 shares through employee stock purchase plan - Stock Titan
BIO-key (BKYI) CTO receives 250-share ESPP award after reverse stock split - Stock Titan
Podcast: HLTH Europe and BIO key trends rundown - Yahoo Finance
Bio-Key International Showcases Passwordless and Biometric Identity Solutions At Jordan Banking Cybersecurity Workshop - marketscreener.com
BIO-key International to Join Jordan Banking Cybersecurity and Identity Workshop in Amman - Moomoo
BIO-key Showcases Passwordless & Biometric Identity - GlobeNewswire
BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th - The Manila Times
BKYI SEC FilingsBio-Key Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BIO-key International (BKYI) Slips 1.96% as Stock Tests Key Support LevelsTRIN Signal - dars.gov.et
BIO-key International (BKYI) Faces Selling Pressure, Testing Key Support Zone at $4.28Jurik MA - dars.gov.et
BKYI Q1 2026 Earnings: Significant EPS Beat Despite Revenue ChallengesNet Profit Margin - dars.gov.et
BIO-key International Q1 2026 Financial Results: Lower Revenues, Continued Net Loss After Reverse Stock Split - Minichart
BIO KEY INTERNATIONAL INC 2026: Revenue $2.15M, EPS ($0.2) — 10-Q Summary - TradingView
BIO-key (OTC: BKYI) posts Q1 2026 loss amid liquidity and Nasdaq listing pressures - Stock Titan
BIO-Key International Inc (BKYI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BIO-key’s Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur. June 25 at 4pm ET - GlobeNewswire
BIO-Key International Inc (BKYI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BIO-Key International Inc (BKYI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BIO-Key International Inc (BKYI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bio Key International Inc Stock (BKYI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):